Point72 Hong Kong LTD Kala Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.62 - $5.43 $26,666 - $55,266	-10,178 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.06 - $8.15 $50,751 - $81,744	10,030 Added 6777.03%	10,178 $54,000
Q1 2021 May 17, 2021	SELL	$6.24 - $9.58 $736 - $1,130	-118 Reduced 44.36%	148 $1,000
Q4 2020 Feb 16, 2021	BUY	$6.28 - $8.79 $1,670 - $2,338	266 New	266 $2,000
Q3 2020 Nov 16, 2020	SELL	$7.5 - $11.11 $54,802 - $81,180	-7,307 Closed	0 $0

Q2 2020 Aug 14, 2020	BUY	$8.33 - $13.79 $60,867 - $100,763	7,307 New	7,307 $77,000
Q1 2020 May 15, 2020	SELL	$3.83 - $8.79 $5,147 - $11,813	-1,344 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.36 - $4.81 $4,515 - $6,464	1,344 New	1,344 $5,000
Q1 2019 May 15, 2019	SELL	$5.19 - $8.97 $2,662 - $4,601	-513 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$4.29 - $9.94 $2,200 - $5,099	513 New	513 $3,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.82M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.